FDA Drug Testing Acceleration Pilot Debuts, Making Speed a New Pressure Point in the U.S.-China Biotech Race
U.S. regulators are trying to move drug testing onto a faster, more flexible path; but behind the limited information available, the real question is not who runs fastest, but whether speed can be achieved without sacrificing safety and the quality of evidence.